Ephraim J. Fuchs

Ephraim J. Fuchs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ephraim J. Fuchs sits on this spectrum.

Ephraim J. Fuchs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ephraim J. Fuchs sits on this spectrum.

Best Publications

• HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

  Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Heather J. Symons;Allen R. Chen

  2099
  Citations

• Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells

  John Paul Ridge;Ephraim J. Fuchs;Polly Matzinger

  1090
  Citations

• B Cells Turn Off Virgin But Not Memory T Cells

  Ephraim J. Fuchs;Polly Matzinger

  828
  Citations

• Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

  Claudio G. Brunstein;Ephraim J. Fuchs;Shelly L. Carter;Chatchada Karanes

  771
  Citations

• Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

  Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey

  695
  Citations

• Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

  P.V O'Donnell;L Luznik;R.J Jones;G.B Vogelsang

  546
  Citations

• High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

  Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  468
  Citations

• HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

  Javier Bolaños-Meade;Ephraim J. Fuchs;Leo Luznik;Sophie M. Lanzkron

  457
  Citations

• Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.

  Rajani Ravi;Gauri. C. Bedi;Laura W. Engstrom;Qinwen Zeng

  454
  Citations

• Durable engraftment of major histocompatibility complex–incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

  Leo Luznik;Sanju Jalla;Laura W. Engstrom;Robert Iannone

  444
  Citations

• Flavopiridol Induces Apoptosis in Chronic Lymphocytic Leukemia Cells Via Activation of Caspase-3 Without Evidence of bcl-2 Modulation or Dependence on Functional p53

  John C. Byrd;Charlotte Shinn;Jamie K. Waselenko;Ephraim J. Fuchs

  430
  Citations

• Is cancer dangerous to the immune system

  Ephraim J. Fuchs;Polly Matzinger

  418
  Citations

• Modern approaches to HLA-haploidentical blood or marrow transplantation

  Christopher G. Kanakry;Ephraim J. Fuchs;Leo Luznik

  403
  Citations

• Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation

  Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Ephraim J. Fuchs

  401
  Citations

• Association of Foxp3 regulatory gene expression with graft-versus-host disease

  Yuji Miura;Christopher J. Thoburn;Emilie C. Bright;Michele L. Phelps

  399
  Citations

• Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

  Christopher G. Kanakry;Sudipto Ganguly;Marianna Zahurak;Javier Bolaños-Meade

  393
  Citations

• Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia

  Robert Iannone;James F Casella;Ephraim J Fuchs;Allen R Chen

  375
  Citations

• Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

  Asad Bashey;Mei Jie Zhang;Shannon R. McCurdy;Andrew St Martin

  369
  Citations

• Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

  Lauri M. Burroughs;Paul V. O'Donnell;Brenda M. Sandmaier;Barry E. Storer

  352
  Citations

• Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

  Shannon R. McCurdy;Jennifer A. Kanakry;Margaret M. Showel;Hua Ling Tsai

  328
  Citations